45
Epidemiologic Study Epidemiologic Study Designs Designs Acknowledgements: M. Tevfik DORAK Ahmed Mandil Ahmed Mandil Kimberly R. Barber Birgit Greiner

Epidemiology Lecture 1

Embed Size (px)

Citation preview

Page 1: Epidemiology Lecture 1

Epidemiologic Study Epidemiologic Study DesignsDesigns

Acknowledgements:

M. Tevfik DORAK

Ahmed MandilAhmed Mandil

Kimberly R. Barber

Birgit Greiner

Page 2: Epidemiology Lecture 1

Study design: Definition

A study design is a specific plan or protocol for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one.

Page 3: Epidemiology Lecture 1

Epidemiologic Study Designs

Experimental Observational

DescriptiveAnalytical

Case-Control Cohort+ cross-sectional & ecologic

(RCTs)

Page 4: Epidemiology Lecture 1

Descriptive studiesDescriptive studies

Examine patterns of disease

Analytical studiesAnalytical studies

Studies of suspected causes of diseases

Experimental studiesExperimental studies

Compare treatment modalities

Epidemiologic Study Designs

Page 5: Epidemiology Lecture 1

Epidemiologic Study Designs

Grimes & Schulz, 2002

Page 6: Epidemiology Lecture 1

Hierarchy of Epidemiologic Study DesignHierarchy of Epidemiologic Study Design

Tower & Spector, 2007

Page 7: Epidemiology Lecture 1

ObservationalObservational Studies Studies

(no control over the circumstances)

- Descriptive: Most basic demographic studies

* Case Report

* Case Series

* Cross sectional

* Ecological/Correlation study

- Analytical: Comparative studies testing an hypothesis * cross-sectional (a snapshot; no idea on cause-and-effect relationship)

* cohort (prospective; cause-and-effect relationship can be inferred)

* case-control (retrospective; cause-and-effect relationship can be inferred)

Page 8: Epidemiology Lecture 1

Epidemiologic Study Designs

Grimes & Schulz, 2002

Page 9: Epidemiology Lecture 1

Case Report• What?

the profile of a single patient is reported in detail by one or more clinicians

• Example

In 1961, a published case report of a 40 year-old women who developed pulmonary embolism after beginning use oral contraceptive

Page 10: Epidemiology Lecture 1

Case Series• What?

An individual case report that has been expanded to include a number of patients with a given disease

• Example

In Los Angeles, five young homosexuals men, previously healthy, were diagnosed with pneumocyst cariini pneumonia in a 6-month period

Page 11: Epidemiology Lecture 1

Ecological or Correlation

• Ecological Studies– whole population is the unit of analysis– relationship between exposure and outcome at the

individual level is missing (incomplete design)

– ecological fallacy

Page 12: Epidemiology Lecture 1

AnalyticalAnalytical Studies Studies

(comparative studies testing an hypothesis)

* cohort (prospective)

Begins with an exposure (smokers and non-smokers)

* case-control (retrospective)

Begins with outcome (cancer cases and healthy controls)

Page 13: Epidemiology Lecture 1

PopulationPeople without disease

Exposed

Not exposed

Disease

No disease

Disease

No disease

Cohort StudiesCohort Studies

Page 14: Epidemiology Lecture 1

Coh

ort D

esig

n

time

Study begins here

Studypopulation

free ofdisease

Factorpresent

Factorabsent

disease

no disease

disease

no disease

presentfuture

Page 15: Epidemiology Lecture 1

Examples of Cohort StudiesExamples of Cohort Studies

*Framingham Heart Study (www)

* Physicians' Health Study (www)

* Nurses' Health Study (www)

Page 16: Epidemiology Lecture 1

Advantages of Cohort StudiesAdvantages of Cohort Studies

- Can establish population-based incidence

- Accurate relative risk (risk ratio) estimation

- Can examine rare exposures (asbestos > lung cancer)

- Temporal relationship can be inferred (prospective design)

- Time-to-event analysis is possible

- Can be used where randomization is not possible

- Magnitude of a risk factor’s effect can be quantified

- Selection and information biases are decreased

- Multiple outcomes can be studied (smoking > lung cancer, COPD, larynx cancer)

Page 17: Epidemiology Lecture 1

Disadvantages of Cohort StudiesDisadvantages of Cohort Studies

- Lengthy and expensive

- May require very large samples

- Not suitable for rare diseases

- Not suitable for diseases with long-latency

- Unexpected environmental changes may influence the association

- Nonresponse, migration and loss-to-follow-up biases

- Sampling, ascertainment and observer biases are still possible

Page 18: Epidemiology Lecture 1

Population Cases (follow up 2 years)

HIV + 215 8HIV - 289 1

Presentation of cohort data: Presentation of cohort data: Population at riskPopulation at risk

Does HIV infection increase risk of developing TB among a population of drug users?

Source: Selwyn et al., New York, 1989EPIET

Page 19: Epidemiology Lecture 1

Relative Risk calculation

Disease Un-disease

Expose a b a+b

Un-expose c d c+d

Incidence in expose (Ie)=a/a+b

Incidence in unexpose (Io)=c/c+d

Relative Risk=Ie/Io

Page 20: Epidemiology Lecture 1

Exposure Population (f/u 2 years)

Cases Incidence

(%) Relative

Risk

HIV +

215

8

3.7

12.3

HIV - 298 1 0.3

Does HIV infection increase risk of developing TB Does HIV infection increase risk of developing TB among drug users?among drug users?

EPIET

Page 21: Epidemiology Lecture 1

time

Exposure Study startsDisease

occurrence

Prospective cohort studyProspective cohort study

time

ExposureStudy startsDisease

occurrence

EPIET

Page 22: Epidemiology Lecture 1

Retrospective cohort studiesRetrospective cohort studies

Exposure

time

Diseaseoccurrence Study starts

EPIET

Page 23: Epidemiology Lecture 1

Cohort StudiesCohort Studies

Grimes & Schulz, 2002

Page 24: Epidemiology Lecture 1

Population

Cases

Controls

Exposed

Case-Control StudiesCase-Control Studies

Not exposed

Exposed

Not exposed

Page 25: Epidemiology Lecture 1

Case-Control StudiesCase-Control Studies

Schulz & Grimes, 2002

Page 26: Epidemiology Lecture 1

Odds ratio calculation

Case Control

Expose a b

Un-expose c d

Odds Ratio =ad/bc

Page 27: Epidemiology Lecture 1

Advantages of Case-Control StudiesAdvantages of Case-Control Studies

- Cheap, easy and quick studies

- Multiple exposures can be examined

- Rare diseases and diseases with long latency can be studied

- Suitable when randomization is unethical (alcohol and pregnancy outcome)

Page 28: Epidemiology Lecture 1

Disadvantages of Case-Control StudiesDisadvantages of Case-Control Studies

- Case and control selection troublesome

- Subject to bias (selection, recall, misclassification)

- Direct incidence estimation is not possible

- Temporal relationship is not clear

- Multiple outcomes cannot be studied

-If the incidence of exposure is high, it is difficult to show the difference between cases and controls

-Reverse causation is a problem in interpretation

Page 29: Epidemiology Lecture 1

Case-Control StudiesCase-Control Studies: :

Potential BiasPotential Bias

Schulz & Grimes, 2002

Page 30: Epidemiology Lecture 1

Application Exercise:Case / Control Study

• Describe a case/control study on the relationship between childhood obesity, smoking history, and occurrence of hypertension in middle-aged men.

• What research question can we answer?

Page 31: Epidemiology Lecture 1

Cross-Sectional Studies

• Measurement of risk and outcome at the same time.

Outcome

Risk factor

Page 32: Epidemiology Lecture 1

Cross-Sectional Design

• The only study capable of calculating prevalence.– Proportion of the

population with the outcome at any point in time.

Page 33: Epidemiology Lecture 1

Application Exercise: Cross-Sectional Study

• Design a cross-sectional study that examines the relationship between dietary sodium and hypertension in middle-aged men.

• What research question can we answer?

Page 34: Epidemiology Lecture 1

Cross-Sectional StudiesAdvantages

• Cheap and quick studies.

• Data is frequently available through current records or statistics.

• Ideal for generating new hypothesis.

Page 35: Epidemiology Lecture 1

Cross-Sectional StudiesDisadvantages

The importance of the relationship between the cause and the effect cannot be determined.

• Temporal weakness:– Cannot determine if cause preceded the effect

or the effect was responsible for the cause.– The rules of contributory cause cannot be

fulfilled.

Page 36: Epidemiology Lecture 1

Type of Study

Alternative Name

Unit of Study

Randomised Controlled Trials

Field Trials

Community Trials

Clinical Trials

Community Intervention Studies

Patients

Healthy People

Communities

Page 37: Epidemiology Lecture 1

Types of trials

B lind ed N o t b lind ed

R a nd o m ised N o t ran d om ised

C o n tro lled N o t co n tro lled

T ria l

Page 38: Epidemiology Lecture 1

Exp

erim

enta

l Des

ign

timeStudy begins here (baseline point)

Studypopulation

Intervention

Control

outcome

no outcome

outcome

no outcome

baselinefuture

RANDOMIZATION

Page 39: Epidemiology Lecture 1

Intervention Randomisation

Control Blinding

Page 40: Epidemiology Lecture 1

Experimental studies are useful for evaluating:

• New drug or other treatment for disease• New medical/health care technology• Methods of prevention• Methods of health promotion• New health protection policies• Programs for screening and diagnosis• Methods of providing health care• New health care policies

Page 41: Epidemiology Lecture 1

Ethical Considerations in experimental studies

• Is proposed treatment safe?• For the sake of trial, can a treatment ethically

be withheld?• What patients may be brought into trial and

allocated randomly to treatments?• Is it ethical to use a placebo or dummy

treatment?• Is it proper for the trial to be in any way

masked?Adapted from Hill (1977)

Page 42: Epidemiology Lecture 1

Advantages (I)

– the “gold standard” of research designs. They thus provide the most convincing evidence of relationship between exposure and effect. Example:

• trials of hormone replacement therapy in menopausal women found no protection for heart disease, contradicting findings of prior observational studies

Page 43: Epidemiology Lecture 1

Advantages (II)

• Best evidence study design• No selection bias (using blinding)• Controlling for possible confounders• Comparable Groups (using

randomization)

Page 44: Epidemiology Lecture 1

Disadvantages

• Is the most expensive study design in terms of money, time, and number of patients.– Issues of patient attrition and compliance may

invalidate the results.– Can be problematic for ethical reasons.

• Use of placebo

• Harm outweighing benefits

• Zero tolerance for some exposures

Page 45: Epidemiology Lecture 1